Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.
Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J; Utah Transplant Affiliated Hospitals (U.T.A.H.) Cardiac Transplant Program.
Ko BS, et al. Among authors: stoddard gj.
J Heart Lung Transplant. 2016 Aug;35(8):1024-30. doi: 10.1016/j.healun.2016.05.001. Epub 2016 May 6.
J Heart Lung Transplant. 2016.
PMID: 27316382
Compared with patients without new sensitization or those already sensitized at baseline, the patients with LVAD-associated sensitization had a higher risk of ACR (p = 0.049) and higher risk of AMR (p = 0.018) but a similar intermediate-term post-transplant survival. The p …
Compared with patients without new sensitization or those already sensitized at baseline, the patients with LVAD-associated sensitization ha …